Medicine & Life Sciences

1. Mesenchymal Stem Cells 100%
2. Multiple Myeloma 79%
3. ponatinib 30%
4. Bone Marrow 26%
5. Hematopoietic Stem Cell Transplantation 23%
6. Allogeneic Cells 19%
7. In Vitro Techniques 19%
8. Cell Transplantation 18%
9. Liquid Biopsy 17%
10. Philadelphia Chromosome 15%
11. Stem Cell Transplantation 15%
12. Cell- and Tissue-Based Therapy 14%
13. Therapeutics 14%
14. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14%
15. Transplants 14%
16. Stem Cells 13%
17. Precursor Cell Lymphoblastic Leukemia-Lymphoma 12%
18. venetoclax 12%
19. caplacizumab 12%
20. Chemokines 12%
21. Hematopoietic Stem Cells 12%
22. Acute Myeloid Leukemia 11%
23. Single-Domain Antibodies 11%
24. Mutation 11%
25. Plasma Exchange 11%
26. Endothelium 10%
27. Prototheca 10%
28. Pityriasis Rubra Pilaris 10%
29. Acquired Thrombotic thrombocytopenic purpura 10%
30. Calgranulin B 10%
31. Macrophage Activation Syndrome 9%
32. carfilzomib 9%
33. Registries 9%
34. cold agglutinins 9%
35. Adult-Onset Still's Disease 9%
36. Tissue Inhibitor of Metalloproteinase-3 9%
37. galactomannan 9%
38. Growth 9%
39. Vorinostat 8%
40. Hepatitis E 8%
41. Hematology 8%
42. Chimerism 8%
43. Interleukin 1 Receptor Antagonist Protein 8%
44. Bortezomib 8%
45. trichostatin A 8%
46. Protein-Tyrosine Kinases 8%
47. fludarabine 7%
48. Thyrotoxicosis 7%
49. Neoplasms 7%
50. Amiodarone 7%